Cargando…
PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols
INTRODUCTION: PCA3 is a non-coding mRNA molecule that is overexpressed in prostate cancer. The purpose of this study is to evaluate the utility of the PCA3 molecular urine test scores to predict adverse pathologic features and catheterized specimen collection. METHODS: Hundred men with clinically lo...
Autores principales: | Liss, Michael A., Santos, Rosanne, Osann, Kathryn, Lau, Alice, Ahlering, Thomas E., Ornstein, David K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189407/ https://www.ncbi.nlm.nih.gov/pubmed/21152924 http://dx.doi.org/10.1007/s00345-010-0623-6 |
Ejemplares similares
-
PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2023) -
Evaluation of Tissue PCA3 Expression in Prostate Cancer by RNA in situ Hybridization - A Correlative Study with Urine PCA3 and TMPRSS2-ERG
por: Warrick, Joshua I., et al.
Publicado: (2013) -
Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples
por: Kotova, Elena S, et al.
Publicado: (2020) -
Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions
por: Wang, Fei, et al.
Publicado: (2021) -
Posterior reconstruction and anterior suspension with single anastomotic suture in robot-assisted laparoscopic radical prostatectomy: a simple method to improve early return of continence
por: Kalisvaart, Jonathan F., et al.
Publicado: (2009)